Macaldowie, A., Lee, E., & Chambers, G. M. (2015). Assisted Reproductive Technology in Australia and New Zealand 2013. AIHW National Perinatal Epidemiology and Statistics Unit.
Macaldowie A, Lee E, Chambers GM. Assisted Reproductive Technology in Australia and New Zealand 2013. AIHW National Perinatal Epidemiology and Statistics Unit; 2015.
Macaldowie, A., et al. Assisted Reproductive Technology in Australia and New Zealand 2013. AIHW National Perinatal Epidemiology and Statistics Unit, 2015.
18% of Australia, NZ ART Cycles Ended in a Live Birth in 2013
This national registry report tracked every ART treatment cycle at Australian and New Zealand fertility clinics in 2013, a total of 71,516 cycles. About 18 out of 100 cycles ended in a live birth, and 24 out of 100 led to a pregnancy. Over three-quarters of liveborn babies (77.5%) were single babies born at term with normal weight.
Key Findings
Clinics in Australia and New Zealand reported 71,516 ART cycles in 2013; 17,054 (23.8%) became a clinical pregnancy and 12,997 (18.2%) ended in a live birth.
Live delivery rates were higher in younger women: 27.2% for autologous fresh cycles in women under 30, versus 1.2% for women over 44.
Australia and New Zealand's multiple birth rate dropped about a third over five years, from 8.2% in 2009 to 5.6% in 2013, as single embryo transfer use grew from 69.7% to 79.2%.
Nearly one baby in six (16.6%) arrived early, roughly double the 8.5% early-arrival rate for all Australian births in 2012; over 12% weighed under 2,500 grams.
Among 14,887 women followed from a first autologous fresh cycle started in 2011, the live birth rate was 20.6% on the first attempt and around 10% after seven cycles.
Interpretation
This is a national clinical registry report of routine practice. The registry counted every cycle from 36 fertility centers in Australia and New Zealand in 2013. So the numbers describe real-world practice. They are not a head-to-head comparison. The overall rates cannot show what would have happened without treatment. Pregnancy and birth data were missing for 1.7% of clinical pregnancies, and follow-up relied partly on self-report. One part of the report followed an actual group of women through repeat cycles. The group only included women who started their first fresh cycle in 2011. The cohort is a smaller, different population than the full 2013 snapshot used elsewhere in this report.
RRM Context
This report is part of the evidence used to compare assisted reproductive technology with restorative reproductive medicine. Restorative care aims to find and treat the cause of infertility, so pregnancy can happen without IVF. Even single babies from ART had more early births (10.5%) than single babies born in Australia overall (6.9%) in 2012. Other national ART registries report similar patterns.
Our editorial summary of this paper, not the article's abstract.
Key figures
Treatment activity, 2013
Measure
Value
Source
Number of ART cycles reported across Australia and New Zealand
71,516
Summary
ART cycles undertaken in Australia
66,143
Summary
ART cycles undertaken in New Zealand
5,373
Summary
Growth in Australian cycle numbers versus the prior year
1.9%
Summary
Growth in New Zealand cycle numbers versus the prior year
3.8%
Summary
Share of treatments using a woman's own eggs or embryos (autologous)
95.1%
Summary
Share of autologous cycles using a previously frozen and thawed embryo
36.6%
Summary
Number of women who had an autologous fresh and/or thaw cycle
37,192
Summary
Total autologous fresh and/or thaw cycles carried out
67,980
Summary
Mean number of fresh and/or thaw cycles per woman
1.8
Summary
Share of autologous-cycle patients aged 40 or over
26.8%
Summary, patient age
Mean age of women having an autologous cycle
35.9
Summary, patient age
Pregnancy and birth outcomes, 2013
Measure
Value
Source
Clinical pregnancy rate per started cycle, with underlying count
23.8% (17,054)
Summary
Live delivery rate per started cycle, with underlying count
18.2% (12,997)
Summary
Clinical pregnancy rate among cycles that reached an embryo transfer
31.0%
Summary
Live delivery rate counted against each started fresh cycle
16.3%
Summary
Live delivery rate counted against each fresh embryo transfer performed
23.7%
Summary
Live delivery rate counted against each started thaw cycle
22.0%
Summary
Live delivery rate, autologous fresh cycles, patients under 30
27.2%
Summary, age and outcomes
Live delivery rate, autologous thaw cycles, patients under 30
27.8%
Summary, age and outcomes
Live delivery rate, autologous fresh cycles, patients over 44
1.2%
Summary, age and outcomes
Live delivery rate, autologous thaw cycles, patients over 44
5.4%
Summary, age and outcomes
Embryo transfer practice, 2013
Measure
Value
Source
Live delivery rate following a cleavage-stage (day 2-3) transfer
16.0%
Summary
Live delivery rate following a blastocyst-stage (day 5-6) transfer
28.4%
Summary
Babies born and multiples, 2013
Measure
Value
Source
Babies resulting from ART treatment, all outcomes
13,939
Summary
Babies resulting from ART treatment who were born alive
13,715
Summary
Share of liveborn babies that were normal-weight, full-term singletons
77.5%
Summary
Multiple births, 2013
Measure
Value
Source
Multiple delivery rate, Australia
5.6%
Summary, multiple birth trends
Multiple delivery rate, New Zealand
5.2%
Summary, multiple birth trends
Five-year trend, 2009 to 2013
Measure
Value
Source
Decline in the combined Australia/New Zealand multiple delivery rate
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.